Richard M. Murray

Richard M. Murray's AcademicInfluence.com Rankings

Richard M. Murray

Engineering

#8821

World Rank

#10443

Historical Rank

Bioengineering

#120

World Rank

#122

Historical Rank

engineering Degrees

Download Badge

Engineering

Richard M. Murray's Degrees

PhD Electrical Engineering and Computer Science University of California, Berkeley
Masters Electrical Engineering and Computer Science University of California, Berkeley
Bachelors Electrical Engineering and Computer Science California Institute of Technology

Why Is Richard M. Murray Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard M. Murray's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine (1995) (1587)
IL-7 is critical for homeostatic proliferation and survival of naïve T cells (2001) (1030)
Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice (1997) (644)
Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. (1995) (455)
Impaired development of Th2 cells in IL-13-deficient mice. (1998) (435)
Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. (2005) (414)
The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. (1997) (360)
Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia (1995) (331)
Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice. (1996) (304)
Mice deficient for the IL-3/GM-CSF/IL-5 βc receptor exhibit lung pathology and impaired immune response, while βIL3 receptor-deficient mice are normal (1995) (292)
DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. (2000) (265)
Regulation of Elastinolytic Cysteine Proteinase Activity in Normal and Cathepsin K–Deficient Human Macrophages (2000) (228)
Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. (1996) (227)
Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection (1996) (219)
Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. (1997) (206)
IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. (1989) (177)
The pulmonary alveolar proteinosis in granulocyte macrophage colony- stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation (1996) (147)
Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice (1997) (139)
Induction of TCR gene rearrangements in uncommitted stem cells by a subset of IL-7 producing, MHC class-II-expressing thymic stromal cells. (1997) (127)
The genes for leukemia inhibitory factor and interleukin-6 are expressed in mouse blastocysts prior to the onset of hemopoiesis (1990) (122)
Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent. (2006) (118)
Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. (1998) (115)
Primary sensory neurons migrate in response to the chemokine RANTES (1998) (90)
Increased vulnerability of dopaminergic neurons in MPTP‐lesioned interleukin‐6 deficient mice (2002) (87)
Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. (1998) (84)
Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes. (1990) (83)
Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. (2004) (78)
Matrilysin-dependent Elastolysis by Human Macrophages (2003) (74)
Uniform Overexpression and Rapid Accessibility of α5β1 Integrin on Blood Vessels in Tumors (2005) (72)
IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis. (1998) (70)
E-selectin up-regulation allows for targeted drug delivery in prostate cancer. (2003) (70)
The Role of IL-7 in Thymic and Extrathymic Development of TCRγδ Cells (1998) (70)
Infection of Mice Lacking Interleukin-7 (IL-7) Reveals an Unexpected Role for IL-7 in the Development of the Parasite Schistosoma mansoni (1999) (60)
Rapid Access of Antibodies to α5β1 Integrin Overexpressed on the Luminal Surface of Tumor Blood Vessels (2005) (58)
The cytokine stew and innate resistance to L. monocytogenes (1997) (55)
NK1.1+ T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production. (1996) (54)
Tumor necrosis factor-alpha and P40 induce day 15 murine fetal thymocyte proliferation in combination with IL-2. (1990) (53)
Differential transport requirements of HLA and H-2 class I glycoproteins (2004) (50)
HNMP-1: A Novel Hematopoietic and Neural Membrane Protein Differentially Regulated in Neural Development and Injury (1997) (49)
Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: transduction of the negative signals by betac and betaIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. (1998) (46)
Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors. (2005) (41)
Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array. (2006) (39)
Peripheral nerve regeneration in interleukin 6-deficient mice. (2000) (38)
Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 β c receptor-deficient mice despite correction of alveolar proteinosis after BMT (1997) (37)
The nucleotide sequence and comparative analysis of the H-2Dp class I H-2 gene. (1986) (32)
Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels. (2005) (30)
Mice Deficient for the Ecto-Nicotinamide Adenine Dinucleotide Glycohydrolase CD38 Exhibit Altered Humoral Immune Responses (1998) (29)
Protective Immunity to Rotavirus Shedding in the Absence of Interleukin-6: Th1 Cells and Immunoglobulin A Develop Normally (2000) (27)
The physiologic role of interleukin‐3, interleukin‐5, granulocyte‐macrophage colony‐stimulating factor, and the βc receptor system (1998) (26)
A single amino acid substitution in an MHC class I molecule allows heteroclitic recognition by lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes. (1991) (25)
The role of IL-7 in thymic and extrathymic development of TCR gamma delta cells. (1998) (20)
Signal transduction by the GM-CSF, IL-3 and IL-5 receptors. (1997) (19)
Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium. (1998) (18)
Saturation mutagenesis of a major histocompatibility complex protein domain: identification of a single conserved amino acid important for allorecognition. (1988) (17)
The Role of IL-7 in Thymic and Extrathymic Development of TCR gd Cells 1 (1998) (16)
Random oligonucleotide mutagenesis: application to a large protein coding sequence of a major histocompatibility complex class I gene, H-2DP. (1988) (14)
Physiologic roles of interleukin‐2, interleukin‐4, and interleukin‐7 (1996) (13)
IL-7 Knockout Mice and the Generation of Lymphocytes (1998) (7)
Mutations in the alpha 1 domain of a class I gene define residues important for specific allorecognition. (1990) (7)
Analysis of novel residues of class I involved in recognition by alloreactive T cells (2004) (2)
M200, an integrin α5β1 antibody, promotes apoptosis in proliferating endothelial cells. (2004) (2)
Non-T Cell Non-B Cell-Mediated Colitis IL-7 Deficiency Prevents Development of a (1998) (1)
Cytokines and development (1990) (1)
Tumorigenesis and Neoplastic Progression Uniform Overexpression and Rapid Accessibility of 1 Integrin on Blood Vessels in Tumors (2005) (0)
The In Vivo Role of the Receptors for IL-3, GM-CSF, and IL-5 (β c and β IL3 ) (1998) (0)
Identification and validation of anti-TMEFF2-Auristatin E conjugated antibodies in the treatment of prostate cancer. (2004) (0)
Inhibition of 5ß1 Integrin Function in Cynomolgus Monkeys with a Potent Function-blocking Fab, Eos200F, Inhibits Angiogenesis in a Laser-induced Model of Choroidal Neovascularization (2003) (0)
Detection of the "Kreisler" (maf B) gene by combination of in situ-hybridization and immunohistochemistry of RA-, osteoarthritis- and normal controls-synovial tissue samplings as a potential significant marker for early RA (2001) (0)
CTLA-8 in combination with G-CSF or G-CSF and IL-6, and use of CTLA-8 for treatment of infections (1996) (0)
Gene disruption of the IL-3/GM-CSF/IL-5 receptor β chains (1994) (0)
Antibodies to cancer antigen tmeff2 and its applications (2003) (0)
Altered Recognition of LCMV Antigen Presented on Mutant Class I Molecules (1990) (0)
Transgenic Mice C-Reactive Protein Gene Expression in Testosterone and IL-6 Requirements for Human (1998) (0)
Development of TCR The Role of IL-7 in Thymic and Extrathymic (1998) (0)
Selected Abstracts of the Institut Pasteur Euroconference on Angiogenesis, Paris, France 8–9 March 2001 (2004) (0)
Defective GM-CSF/IL3/IL5 receptor common β chain expression with or without AML associated with respiratory insufficiency (1998) (0)
Random Mutagenesis by Oligonucleotides: A Probe for MHC Structure and Function (1990) (0)
Using anti-alfa5beta1-antibodies to inhibit kræftcelleproliferation (2005) (0)
IL-6 deficient mice exhibit a neutrophil activation defect in opportunistic infections (1994) (0)
M200 (volociximab), a chimeric antibody against integrin alpha5 beta1, inhibits tumor growth by multiple mechanisms (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard M. Murray?

Richard M. Murray is affiliated with the following schools: